Lioton

Heparin Sodium, the active ingredient in Lioton, is an anticoagulant presented as a topical formulation for external use. It helps prevent clot formation and is used in the management of superficial vascular conditions and catheter‑related thrombosis.

GNH USA supplies Lioton as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Lioton is a topical anticoagulant that acts on superficial vascular and catheter‑related clotting pathways.

Superficial thrombophlebitis: reduces inflammation and limits clot extension. Catheter‑related thrombosis prophylaxis: helps maintain catheter patency by inhibiting local clot formation. Bruising/hematoma management: promotes resorption of blood collections and limits further clotting.

Lioton may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Skin irritation or redness at the application site - Itching or mild burning sensation - Local pain or tenderness - Erythema - Mild allergic dermatitis - Dryness of the treated skin

Serious or Rare Side Effects: - Severe hypersensitivity or anaphylaxis - Heparin‑induced thrombocytopenia (HIT) with potential bleeding - Necrosis of the skin at the site of application - Systemic anticoagulation leading to unexpected bleeding - Thrombocytopenia with platelet count drop - Rare cases of disseminated intravascular coagulation

When using Lioton, consider the following safety measures.

Assess for heparin allergy: discontinue if hypersensitivity occurs. Monitor for bleeding: observe the site for excessive bruising or hemorrhage. Avoid on open wounds: do not apply to broken or infected skin. Use with caution in clotting disorders: evaluate bleeding risk before application. Do not combine with other topical anticoagulants: avoid additive anticoagulant effects. Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Lioton may interact with other agents that affect coagulation.

Major Interactions (Avoid): - Systemic anticoagulants (e.g., warfarin, direct oral anticoagulants) – increased bleeding risk. - Thrombolytic agents – additive anticoagulant effect. - High‑dose aspirin or other potent antiplatelet drugs – heightened hemorrhagic potential.

Moderate Interactions (Monitor Closely): - Oral antiplatelet agents (e.g., clopidogrel, aspirin) – monitor for local bleeding. - Topical corticosteroids – may alter skin absorption. - Herbal supplements with anticoagulant properties (e.g., ginkgo, garlic) – assess bleeding tendency. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied nearby – watch for combined irritation and bleeding.